DCM
PRTK

Deuterium Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Deuterium Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-55,136
Closed -$122K – 112
2023
Q2 		$122K Buy
+55,136
New +$122K 0.16% 85